2-n,n-di-n-propylamino-4,7-dimethoxyindan has been researched along with oxotremorine in 1 studies
| Studies (2-n,n-di-n-propylamino-4,7-dimethoxyindan) | Trials (2-n,n-di-n-propylamino-4,7-dimethoxyindan) | Recent Studies (post-2010) (2-n,n-di-n-propylamino-4,7-dimethoxyindan) | Studies (oxotremorine) | Trials (oxotremorine) | Recent Studies (post-2010) (oxotremorine) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 1,930 | 6 | 99 |
| Protein | Taxonomy | 2-n,n-di-n-propylamino-4,7-dimethoxyindan (IC50) | oxotremorine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.4 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 5 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 2.321 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.7261 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.7261 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.7261 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 8 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.7261 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.5012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilhan, M; Sahin, I; Tuncer, M | 1 |
1 other study(ies) available for 2-n,n-di-n-propylamino-4,7-dimethoxyindan and oxotremorine
| Article | Year |
|---|---|
Dopamine receptor agonists, N,N-dipropyl-2-aminotetralin (TL-68) and 2-di-n-propylamino-4,7-dimethoxyindane (RDS-127) antagonize oxotremorine-induced tremors by antimuscarinic action in mice.
Topics: Animals; Atropine; Dopamine Agents; Indans; Indenes; Male; Mice; Naphthalenes; Oxotremorine; Parasympatholytics; Tetrahydronaphthalenes; Tremor | 1990 |